483 related articles for article (PubMed ID: 32811575)
1. Psychedelic science in post-COVID-19 psychiatry.
Kelly JR; Crockett MT; Alexander L; Haran M; Baker A; Burke L; Brennan C; O'Keane V
Ir J Psychol Med; 2021 Jun; 38(2):93-98. PubMed ID: 32811575
[TBL] [Abstract][Full Text] [Related]
2. The psychedelic renaissance: the next trip for psychiatry?
Kelly JR; Baker A; Babiker M; Burke L; Brennan C; O'Keane V
Ir J Psychol Med; 2022 Dec; 39(4):335-339. PubMed ID: 31543078
[TBL] [Abstract][Full Text] [Related]
3. [Psilocybin compared with escitalopram for depression].
Strous JFM
Ned Tijdschr Geneeskd; 2022 Jan; 166():. PubMed ID: 35138714
[TBL] [Abstract][Full Text] [Related]
4. Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.
Erritzoe D; Barba T; Spriggs MJ; Rosas FE; Nutt DJ; Carhart-Harris R
J Psychopharmacol; 2024 May; 38(5):458-470. PubMed ID: 38520045
[TBL] [Abstract][Full Text] [Related]
5. Psychedelic Medicines in Major Depression: Progress and Future Challenges.
Bouso JC; Ona G; Dos Santos RG; Hallak JEC
Adv Exp Med Biol; 2021; 1305():515-533. PubMed ID: 33834416
[TBL] [Abstract][Full Text] [Related]
6. Trial of Psilocybin versus Escitalopram for Depression.
Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
[TBL] [Abstract][Full Text] [Related]
8. Psychiatry goes psychedelic.
O'Leary K
Nat Med; 2021 Dec; 27(12):2056-2057. PubMed ID: 34907384
[No Abstract] [Full Text] [Related]
9. Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.
Kelly JR; Gillan CM; Prenderville J; Kelly C; Harkin A; Clarke G; O'Keane V
Front Psychiatry; 2021; 12():800072. PubMed ID: 34975593
[TBL] [Abstract][Full Text] [Related]
10. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.
Sousa TR; Rema J; Machado S; Novais F
Curr Top Med Chem; 2022; 22(15):1250-1260. PubMed ID: 34852736
[TBL] [Abstract][Full Text] [Related]
11. Psychedelic Psychiatry's Brave New World.
Nutt D; Erritzoe D; Carhart-Harris R
Cell; 2020 Apr; 181(1):24-28. PubMed ID: 32243793
[TBL] [Abstract][Full Text] [Related]
12. Psychedelic drugs-a new era in
psychiatry?
.
Nutt D
Dialogues Clin Neurosci; 2019; 21(2):139-147. PubMed ID: 31636488
[TBL] [Abstract][Full Text] [Related]
13. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
Carhart-Harris RL; Bolstridge M; Day CMJ; Rucker J; Watts R; Erritzoe DE; Kaelen M; Giribaldi B; Bloomfield M; Pilling S; Rickard JA; Forbes B; Feilding A; Taylor D; Curran HV; Nutt DJ
Psychopharmacology (Berl); 2018 Feb; 235(2):399-408. PubMed ID: 29119217
[TBL] [Abstract][Full Text] [Related]
14. Role of Psychedelics in Treatment-Resistant Depression.
Kamal S; Jha MK; Radhakrishnan R
Psychiatr Clin North Am; 2023 Jun; 46(2):291-305. PubMed ID: 37149346
[TBL] [Abstract][Full Text] [Related]
15. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
Pearson C; Siegel J; Gold JA
J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
[TBL] [Abstract][Full Text] [Related]
16. Potential Therapeutic Effects of Psilocybin.
Johnson MW; Griffiths RR
Neurotherapeutics; 2017 Jul; 14(3):734-740. PubMed ID: 28585222
[TBL] [Abstract][Full Text] [Related]
17. Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
Corrigan K; Haran M; McCandliss C; McManus R; Cleary S; Trant R; Kelly Y; Ledden K; Rush G; O'Keane V; Kelly JR
Ir J Med Sci; 2022 Jun; 191(3):1385-1397. PubMed ID: 34131812
[TBL] [Abstract][Full Text] [Related]
18. Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.
Thomas K; Malcolm B; Lastra D
J Psychoactive Drugs; 2017; 49(5):446-455. PubMed ID: 28481178
[TBL] [Abstract][Full Text] [Related]
19. [The use of psilocybin for treatment-resistant depression].
Johannesdottir A; Sigurdsson E
Laeknabladid; 2022 Sep; 108(9):403-410. PubMed ID: 36040772
[TBL] [Abstract][Full Text] [Related]
20. Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.
Mertens LJ; Preller KH
Pharmacopsychiatry; 2021 Jul; 54(4):176-190. PubMed ID: 33472250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
